Patients Versus Patents: Thailand and the Politics of Access to Pharmaceuticals Products
Journal of Third World Studies, 27(1), April 2010
Ann Marie Murphy, Ph.D.
School of Diplomacy and International Relations
The article examines the compulsory licensing of pharmaceutical drugs in Thailand and discusses how the decision by the Thai government to break patents on drugs used to treat non-infectious, chronic diseases could dramatically alter the global patent system. It examines the World Trade Organization's Agreement on Trade-Related Aspects of Intellectual Property Rights and discusses how it has been applied to pharmaceuticals prior to Thailand's 2006 decision to issue a compulsory license on the HIV/AIDS drug Efavirenz. It explores the global reaction to this decision and discusses how it has affected the balance of power of the international politics of pharmaceuticals.